Thrombosis

Getting sick with COVID-19 carries an eight to tenfold higher risk of developing blood clots in the brain than the AstraZeneca vaccine – and by extension, most likely, the Johnson & Johnson vaccine – a new study suggests.

Why might some COVID-19 vaccines pose a small risk of blood clots while others don't? Scientists suspect it's related to their use of adenoviruses.

Administration of the Johnson & Johnson vaccine was halted on April 13 2021, leading to a 'perfect storm' of medical disinformation.

According to a recent report, a whopping 5,800 Americans have contracted COVID-19 despite being fully vaccinated with either the single-shot Johnson & Johnson, the double-shot Moderna or the double-shot Pfizer vaccine.

The risk of the vaccine causing blood clots might still turn out to be insignificant. But from Europe to Africa, the U.S. 'pause' on the J&J vaccine has had dramatic fallout.

Get a hematologist involved, CDC staff urge

Injections of the Johnson & Johnson coronavirus vaccine came to a sudden halt this week in the United States after a small number of rare blood clots emerged, though it is unclear if the shot was responsible.

Pennsylvania vaccine providers will not administer Johnson & Johnson vaccine until at least April 24, state officials said Thursday, extending the distribution pause by four days. Federal regulators had recommended a pause in the single-shot vaccine Tuesday, after six women were reported to experience blood clots and low platelet counts

No, We Should Not Be Pausing the J&J Vaccine | RealClearPolitics

All in all, the risk of blood clots from the J&J vaccine is extremely low when compared to the risk of blood clots in other contexts, writes Céline Gounder, who points to the fact that the six blood clot cases are out of over 1 million women in the 20-50 age group who have received doses of J&J.

124 votes and 72 comments so far on Reddit

An emergency meeting of a Centers for Disease Control and Prevention advisory committee was held to discuss the extremely rare blood clots possibly associated with the Johnson and Johnson COVID-19 vaccine. The meeting ended without a decision on when the shots can be given again. CBS News' Laura Podesta joined "CBSN AM" with the latest.

A Centers for Disease Control and Prevention (CDC) committee learned Wednesday of a seventh woman who developed a rare and severe type of blood clot after receiving the J&JCOVID-19 vaccine, and a man whose occurred during clinical trial, but it could not be linked to the jab at the time.

New Mexico, which has one of the highest poverty rates in the U.S., is a vaccination pacesetter thanks to decisive political decisions, homegrown technology and cooperation.

Adenoviruses are an obvious link, but a puzzling suspect in the dangerous cases.

A Pennsylvania woman was one of six people in the U.S. who were hospitalized with blood clot issues after receiving the Johnson & Johnson coronavirus vaccine,…

The panel said it did not have enough information to make a decision on the vaccine's safety. Some praised the conclusion; some say it will have severe consequences.

An advisory committee debated the very few cases of a rare blood disorder and worried about the suspension's effect on global needs for a one-shot, easy-to-ship vaccine.

The AstraZeneca and Johnson & Johnson shots are both viral vector vaccines. Both have been linked to cases of rare blood clots in the brain.

A Tennessee woman, who was hospitalized for blood clots after receiving the Johnson & Johnson COVID-19 vaccine, is speaking out about her ordeal. The unidentified patient spoke with several med…